Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ
Open accessAbstract
Epidemiological evidence suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) decrease the risk for Alzheimer's disease (AD). Certain NSAIDs can activate the peroxisome proliferator-activated receptor-γ (PPARγ), which is a nuclear transcriptional regulator. Here we show that PPARγ depletion potentiates β-secretase [β-site amyloid precursor protein cleaving enzyme (BACE1)] mRNA levels by increasing BACE1 gene promoter activity. Conversely, overexpression of PPARγ, as well as NSAIDs and PPARγ activators, reduced BACE1 gene promoter activity. These results suggested that PPARγ could be a repressor of BACE1. We then identified a PPARγ responsive element (PPRE) in the BACE1 gene promoter. Mutagenesis of the PPRE abolished the binding of PPARγ to the PPRE and increased BACE1 gene promoter activity. Furthermore, proinflammatory cytokines decreased PPARγ gene transcription, and this effect was supressed by NSAIDs. We also demonstrate that in vivo treatment with PPARγ agonists increased PPARγ and reduced BACE1 mRNA and intracellular β-amyloid levels. Interestingly, brain extracts from AD patients showed decreased PPARγ expression and binding to PPRE in the BACE1 gene promoter. Our data strongly support a major role of PPARγ in the modulation of amyloid-β generation by inflammation and suggest that the protective mechanism of NSAIDs in AD involves activation of PPARγ and decreased BACE1 gene transcription.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PPARγ has also been reported to reduce intraneuronal amyloid in APPV7171 and 3XTg mouse models of Alzheimer's disease following Pioglitazone treatment.
“PPARγ has also been reported to reduce intraneuronal amyloid in APPV7171 and 3XTg mouse models of AD following Pioglitazone treatment4445.”
From Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease (2017) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · see citing works
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,533 · see citing works
C/EBPα induces adipogenesis through PPARγ: a unified pathwayPreprint
Rosen, E. D., Hsu, C.-H., Wang, X., Sakai, S., Freeman, M. W., Gonzalez, F. J., & Spiegelman, B. M. (2002) · Genes & Development · doi:10.1101/gad.948702 · Cited by 1,497 · see citing works
Self-citationKliewer, S. A., FORMAN, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400 · see citing works
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · see citing works
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196 · see citing works
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110 · see citing works
Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., & Green, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05072.x · Cited by 895 · see citing works
Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease
Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W. K., Teter, B., Tran, T., Ubeda, O. J., Ashe, K. H., Frautschy, S. A., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05709.2000 · Cited by 876 · see citing works
Li, A. C., Brown, K. K., Silvestre, M., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 833 · see citing works
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634 · see citing works
Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., O'Banion, K., Klockgether, T., Van Leuven, F., & Landreth, G. E. (2005) · Brain · doi:10.1093/brain/awh452 · Cited by 565 · see citing works
Self-citationIncreased expression of the amyloid precursor β‐secretase in Alzheimer's disease
Holsinger, R. M. D., McLean, C. A., Beyreuther, K., Masters, C. L., & Evin, G. (2002) · Annals of Neurology · doi:10.1002/ana.10208 · Cited by 562 · see citing works
Ohno, M., Sametsky, E. A., Younkin, L. H., Oakley, H., Younkin, S. G., Citron, M., Vassar, R., & Disterhoft, J. F. (2004) · Neuron · doi:10.1016/s0896-6273(03)00810-9 · Cited by 549 · see citing works
Li, R., Lindholm, K., Yang, L., Yue, X., Citron, M., Yan, R., Beach, T. G., Sue, L. I., Sabbagh, M. N., Cai, H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0205689101 · Cited by 493 · see citing works
Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., Citron, M., & Landreth, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07504.2003 · Cited by 469 · see citing works
Self-citationNonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic Review
Szekely, C. A., Thorne, J. E., Zandi, P. P., Ek, M., Messias, E., Breitner, J. C. S., & Goodman, S. N. (2004) · Neuroepidemiology · doi:10.1159/000078501 · Cited by 394 · see citing works
Oxidative stress increases expression and activity of BACE in NT2 neurons
Tamagno, E., Bardini, P., Obbili, A., Vitali, A., Borghi, R., Zaccheo, D., Pronzato, M. A., Danni, O., Smith, M. A., Perry, G., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0515 · Cited by 385 · see citing works
Sastre, M., Dewachter, I., Landreth, G. E., Willson, T. M., Klockgether, T., LEUVEN, F. V., & Heneka, M. T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-30-09796.2003 · Cited by 359 · see citing works
Self-citationGimble, J. M., Robinson, C. E., Wu, X., Kelly, K. A., Rodriguez, B., Kliewer, S. A., Lehmann, J. M., & Morris, D. C. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09536-7 · Cited by 295 · see citing works
β-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain
Fukumoto, H., Rosene, D. L., Moss, M. B., Raju, S., Hyman, B. T., & Irizarry, M. C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63159-8 · Cited by 294 · see citing works
Heneka, M. T., Klockgether, T., & Feinstein, D. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06862.2000 · Cited by 269 · see citing works
Self-citationTranscriptional Regulation of BACE1, the β-Amyloid Precursor Protein β-Secretase, by Sp1
Christensen, M. A., Zhou, W., Qing, H., Lehman, A., Philipsen, S., & Song, W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.865-874.2004 · Cited by 218 · see citing works
Nonsteroidal anti-inflammatory drugs lower Aβ42 and change presenilin 1 conformation
Lleó, A., Berezovska, O., Herl, L. D., Raju, S., Deng, A., Bacskai, B. J., Frosch, M. P., Irizarry, M. C., & Hyman, B. T. (2004) · Nature Medicine · doi:10.1038/nm1112 · Cited by 198 · see citing works
Xing, H. Y., Northrop, J. P., Grove, J. R., Kilpatrick, K. E., Su, J., & RINGOLD, G. M. (1997) · Endocrinology · doi:10.1210/endo.138.7.5242 · Cited by 189 · see citing works
Blasko, I., Beer, R., Bigl, M., Apelt, J., Franz, G., Rudzki, D., Ransmayr, G. N., Kampfl, A., & Schliebs, R. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0095-6 · Cited by 183 · see citing works
Gene structure and organization of the human β‐secretase ( BACE ) promoter
Sambamurti, K., Kinsey, R., Maloney, B., Ge, Y., & Lahiri, D. K. (2004) · The FASEB Journal · doi:10.1096/fj.03-1378fje · Cited by 179 · see citing works
Luo, Y. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00104-9 · Cited by 169 · see citing works
Peroxisome Proliferator-Activated Receptor γ Induces a Clearance Mechanism for the Amyloid-β Peptide
Espuny-Camacho, I., Serneels, L., Spittaels, K., Merchiers, P., Dominguez, D. I., & Strooper, B. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3987-04.2004 · Cited by 169 · see citing works
Sung, S., Yang, H., Uryu, K., Lee, E. B., Zhao, L., Shineman, D. W., Trojanowski, J. Q., Lee, V. M. ‐., & Praticò, D. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63269-5 · Cited by 154 · see citing works
Jaradat, M., Wongsud, B., Phornchirasilp, S., Rangwala, S. M., Shams, G. E.-D. A. M., Sutton, M., Romstedt, K. J., Noonan, D. J., & Feller, D. R. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00822-x · Cited by 110 · see citing works
Ibuprofen Decreases Cytokine-Induced Amyloid Beta Production in Neuronal Cells
Blasko, I., Apochal, A., Boeck, G., Hartmann, T., Grubeck‐Loebenstein, B., & Ransmayr, G. N. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0451 · Cited by 92 · see citing works
Rogers, G. W., Edelman, G. M., & Mauro, V. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308576101 · Cited by 91 · see citing works
Kudo, M., Sugawara, A., Uruno, A., Takeuchi, K., & Ito, S. (2004) · Endocrinology · doi:10.1210/en.2004-0180 · Cited by 69 · see citing works
Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid.
Bannwarth, B., Lapicque, F., Péhourcq, F., et al. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05783.x · Cited by 61 · see citing works
Plasma and cerebrospinal fluid concentrations of indomethacin in humans
Bannwarth, B., Netter, P., Lapicque, F., Pr, P., Thomas, P., & Gaucher, A. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315572 · Cited by 56 · see citing works
Cloning and expression of the rat BACE1 promoter
Lange‐Dohna, C., Zeitschel, U., Gaunitz, F., et al. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10639 · Cited by 55 · see citing works
Flagged first, then by citations
Research works printed but not linked: 40
- [1]Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S, Amarante, P., Loeloff, R., et al. (1999) Science 286, 735-741. [DOI] [PubMed] [Google Scholar]
- [2]Luo, Y., Bolon, B., Damore, M. A., Fitzpatrick, D., Liu, H., Zhang, J., Yan, Q., Vassar, R. & Citron, M. (2003) Neurobiol. Dis. 14, 81-88. [DOI] [PubMed] [Google Scholar]
- [3]Ohno, M., Sametsky, E. A., Younkin, L. H., Oakley, H., Younkin, S. G., Citron, M., Vassar, R. & Disterhoft, J. F. (2004) Neuron 41, 27-33. [DOI] [PubMed] [Google Scholar]
- [4]Tamagno, E., Bardini, P., Obbili, A., Vitali, A., Borghi, R., Zaccheo, D., Pronzato, M. A., Danni, O., Smith, M. A., Perry, G. & Tabato, M. (2002) Neurobiol. Dis. 10, 279-288. [DOI] [PubMed] [Google Scholar]
- [5]Hartlage-Rubsamen, M., Zeitschel, U., Apelt, J., Gartner, U., Franke, H., Stahl, T., Gunther, A., Schliebs, R., Penkowa, M., Bigl, V. & Rossner, S. (2003) Glia 4, 169-179. [DOI] [PubMed] [Google Scholar]
- [6]Blasko, I., Beer, R., Bigl, M., Apelt, J., Franz, G., Rudzki, D., Ransmayr, G., Kampfl, A. & Schliebs, R. (2004) J. Neural Transm. 111, 523-536. [DOI] [PubMed] [Google Scholar]
- [7]Holsinger, R. M., McLean, C. A., Beyreuther, K., Masters, C. L. & Evin, G. (2002) Ann. Neurol. 51, 783-786. [DOI] [PubMed] [Google Scholar]
- [8]Fukumoto, H., Rosene, D. L., Moss, M. B., Raju, S., Hyman, B. T. & Irizarry, M. C. (2004) Am. J. Pathol. 164, 719-725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9]Li, R., Lindholm, K., Yang, L. B., Yue, X., Citron, M., Yan, R., Beach, T., Sue, L., Sabbagh, M., Ca, H., et al. (2004) Proc. Natl. Acad. Sci. USA 101, 3632-3637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10]Rogers, G. W., Jr., Edelman, G. M. & Mauro, V. P. (2003) Proc. Natl. Acad. Sci. USA 101, 2794-2799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11]Lange-Dohna, C., Zeitschel, U., Gaunitz, F., Perez-Polo, J. R., Bigl, V. & Rossner, S. (2003) J. Neurosci. Res. 73, 73-80. [DOI] [PubMed] [Google Scholar]
- [12]Christensen, M. A., Zhou, W., Qing, H., Lehman, A., Philipsen, S. & Song, W. (2004) Mol. Cell. Biol. 24, 865-784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13]Sambamurti, K., Kinsey, R., Maloney, B., Ge, Y. W. & Lahiri, D. K. (2004) FASEB J. 18, 1034-1036. [DOI] [PubMed] [Google Scholar]
- [14]Sastre, M., Dewachter, I., Landreth, G. E., Willson, T. M., Klockgether, T., van Leuven, F. & Heneka, M. T. (2003) J. Neurosci. 23, 9796-9804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15]Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M. & Kliewer, S. A. (1997) J. Biol. Chem. 272, 3406-3410. [DOI] [PubMed] [Google Scholar]
- [16]Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K. & Evans, R.M. (1994) Proc. Natl. Acad. Sci. USA 91, 7355-7359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17]Tontonoz, P., Hu, E. & Spiegelman, B. M. (1994) Cell 79, 1147-1156. [DOI] [PubMed] [Google Scholar]
- [18]Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L. & Green, S. (1992) EMBO J. 11, 433-439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19]Li, A. C., Brown, K. K., Silvestre, M. J., Willson, T. M., Palinski, W. & Glass, C. K. (2000) J. Clin. Invest. 106, 523-531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20]Rosen, E. D., Hsu, C. H., Wang, X., Sakai, S., Freeman, M. W., Gonzalez, F. J. & Spiegelman, B. M. (2002) Genes Dev. 16, 22-26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21]Heneka, M. T., Klockgether, T. & Feinstein, D. L. (2000) J. Neurosci. 20, 6862-6867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22]Blasko, I. Apochal, A., Boeck, G., Hartmann, T., Grubeck-Loebenstein, B. & Ransmayr, G. (2001) Neurobiol. Dis. 8, 1094-1101. [DOI] [PubMed] [Google Scholar]
- [23]Xing, H. Northrop, J. P., Grove, J. R., Kilpatric, K. E., Su, J.-L. & Ringold, G. M. (1997) Endocrinology 138, 2776-2783. [DOI] [PubMed] [Google Scholar]
- [24]Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., O'Banion, K., Klockgether, T., Van Leuven, F. & Landreth, G. E. (2005). Brain 128, 1442-1453. [DOI] [PubMed] [Google Scholar]
- [25]Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M., Fiebich, B. L., et al. (2000) Neurobiol. Aging 21, 383-421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [26]Szekely, C. A., Thorne, J. E., Zandi, P. P., Ek, M., Messias, E., Breitner, J. C. & Goodman, S. N. (2004) Neuroepidemiology 23, 159-169. [DOI] [PubMed] [Google Scholar]
- [27]Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., Teter, B., Tran, T., Ubeda, O., Ashe, K. H., Frautschy, S. A. & Cole, G. M. (2000) J. Neurosci. 20, 5709-5714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28]Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) Nature 414, 212-216. [DOI] [PubMed] [Google Scholar]
- [29]Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) J. Clin. Invest. 112, 440-449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30]In't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B. & Stricker, B. H. C. (2001) N. Engl. J. Med. 345, 1515-1521. [DOI] [PubMed] [Google Scholar]
- [31]Camacho, I. E., Serneels, L., Spittaels, K., Merchiers, P., Dominguez, D. & De Strooper, B. (2004) J. Neurosci. 24, 10908-10917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [32]Lleo, A., Berezovska, O., Herl, L., Raju, S., Deng, A., Bacskai, B. J., Frosch, M. P., Irizarry, M. & Hyman, B. T. (2004) Nat. Med. 10, 1065-1066. [DOI] [PubMed] [Google Scholar]
- [33]Gimble, J. M., Robinson, C. E., Wu, X., Kelly, K. A., Rodriguez, B. R., Kliewer, S. A., Lehmann, J. M. & Morris, D. C. (1996) Mol. Pharmacol. 50, 1087-1094. [PubMed] [Google Scholar]
- [34]Kudo, M., Sugawara, A., Uruno, A., Takeuchi, K. & Ito, S. (2004) Endocrinology 145, 4948-4956. [DOI] [PubMed] [Google Scholar]
- [35]Klotz, L., Schmidt, M., Sastre, M., Giese, T., Knolle, P., Klockgether, T. & Heneka, M. T. (2005) J. Immunol. 35, 4948-4955. [DOI] [PubMed] [Google Scholar]
- [36]Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., Citron, M. & Landreth, G. (2003) J. Neurosci. 23, 7504-7509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [37]Sung, S., Yang, H., Uryu, K., Lee, E. B., Zhao, L., Shineman, D., Trojanowski, J. Q., Lee, V. M. & Pratico, D. (2004) Am. J. Pathol. 165, 2197-2206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [38]Jaradat, M. S., Wongsud, B., Phornchirasilp, S., Rangwala, S. M., Shams, G., Sutton, M., Romstedt, K. J., Noonan, D. J. & Feller, D. R. (2001) Biochem. Pharmacol. 62, 1587-1595. [DOI] [PubMed] [Google Scholar]
- [39]Bannwarth, B., Netter, P., Lapicque, F., Pere, P., Thomas, P. & Gaucher, A. (1990) Eur. J. Clin. Pharmacol. 38, 343-346. [DOI] [PubMed] [Google Scholar]
- [40]Bannwarth, B., Lapicque, F., Pehourcq, F., Gillet, P., Schaeverbeke, T., Laborde, C., Dehais, J., Gaucher, A. & Netter, P. (1995) Br. J. Clin. Pharmacol. 40, 266-269. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cited by
Sorted by citations
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284 · see citing works
Glial cells in (patho)physiology
Parpura, V., Heneka, M. T., Montana, V., Oliet, S. H. R., Schousboe, A., Haydon, P. G., Stout, R. F., Spray, D. C., Reichenbach, A., Pannicke, T., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07664.x · Cited by 561 · see citing works
Self-citationThe Alzheimer's disease Beta-secretase enzyme, BACE1
Cole, S. L., & Vassar, R. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-22 · Cited by 550 · see citing works
Bazan, N. G., Molina, M. F., & Gordon, W. C. (2011) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104635 · Cited by 441 · see citing works
Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., Liao, F.-F., Xu, H., & Zhang, Y.-W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608856200 · Cited by 436 · see citing works
Neuroinflammatory processes in Alzheimer’s disease
Heneka, M. T., O’Banion, M. K., Terwel, D., & Kummer, M. P. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0438-z · Cited by 433 · see citing works
Self-citationChen, C.-H., Zhou, W., Liu, S., Deng, Y., Cai, F., Tone, M., Tone, Y., Tong, Y., & Song, W. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000149 · Cited by 433 · see citing works
Inflammatory process in Alzheimer's Disease
Meraz-Ríos, M. A., Toral-Rios, D., Franco-Bocanegra, D., Villeda-Hernández, J., & Campos-Peña, V. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00059 · Cited by 427 · see citing works
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms
Sastre, M., Klockgether, T., & Heneka, M. T. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.014 · Cited by 426 · see citing works
Self-citationHe, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705042 · Cited by 390 · see citing works
Michelucci, A., Heurtaux, T., Grandbarbe, L., Morga, E., & Heuschling, P. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.02.003 · Cited by 411 · see citing works
Chen, Y., Zhou, K., Wang, R., Liu, Y., Kwak, Y.-D., Ma, T., Thompson, R. C., Zhao, Y., Smith, L., Gasparini, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807991106 · Cited by 390 · see citing works
Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
Rojo, L. E., Fernández, J. A., Maccioni, A. A., Jimenez, J. M., & Maccioni, R. B. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.10.001 · Cited by 351 · see citing works
Lumeng, C. N., Liu, J., Geletka, L., Delaney, C., Delproposto, J., Desai, A., Oatmen, K., Martinez-Santibanez, G., Julius, A., Garg, S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102188 · Cited by 328 · see citing works
HENEKA, M., & LANDRETH, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.016 · Cited by 317 · see citing works
Self-citationEscribano, L., Simón, A.-M., Gimeno, E., Cuadrado-Tejedor, M., López de Maturana, R., García-Osta, A., Ricobaraza, A., Pérez-Mediavilla, A., Del Río, J., & Frechilla, D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.32 · Cited by 235 · see citing works
TREM2 and the neuroimmunology of Alzheimer's disease
Hickman, S. E., & El Khoury, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.021 · Cited by 221 · see citing works
Zhong, Z., Ewers, M., Teipel, S., Bürger, K., Wallin, A., Blennow, K., He, P., McAllister, C., Hampel, H., & Shen, Y. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.718 · Cited by 206 · see citing works
Valles, S. L., Dolz-Gaiton, P., Gambini, J., Borras, C., LLoret, A., Pallardo, F. V., & Viña, J. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.044 · Cited by 186 · see citing works
Jennewein, C., von Knethen, A., Schmid, T., & Brüne, B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066399 · Cited by 183 · see citing works
Chami, L., & Checler, F. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-52 · Cited by 168 · see citing works
Searcy, J. L., Phelps, J. T., Pancani, T., Kadish, I., Popovic, J., Anderson, K. L., Beckett, T. L., Murphy, M. P., Chen, K.-C., Blalock, E. M., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111661 · Cited by 154 · see citing works
Katsouri, L., Lim, Y. M., Blondrath, K., Eleftheriadou, I., Lombardero, L., Birch, A. M., Mirzaei, N., Irvine, E. E., Mazarakis, N. D., & Sastre, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606171113 · Cited by 146 · see citing works
Self-citationTracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging
Zimmer, E. R., Leuzy, A., Benedet, A. L., Breitner, J., Gauthier, S., & Rosa-Neto, P. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-120 · Cited by 121 · see citing works
Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease
Mariani, M. M., Malm, T., Lamb, R., Jay, T. R., Neilson, L., Casali, B., Medarametla, L., & Landreth, G. E. (2017) · Scientific Reports · doi:10.1038/srep42270 · Cited by 98 · see citing works
Self-citationNuclear receptors in neurodegenerative diseases
Skerrett, R., Malm, T., & Landreth, G. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.019 · Cited by 94 · see citing works
Self-citationMolecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases
Lleo, A., Galea, E., & Sastre, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6516-1 · Cited by 93 · see citing works
Self-citationDepletion of GGA1 and GGA3 Mediates Postinjury Elevation of BACE1
Walker, K. R., Kang, E. L., Whalen, M. J., Shen, Y., & Tesco, G. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5491-11.2012 · Cited by 66 · see citing works
Geng, L., Zhang, T., Liu, W., & Chen, Y. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.9.1096 · Cited by 65 · see citing works
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
Mattsson, N., Axelsson, M., Haghighi, S., Malmeström, C., Wu, G., Anckarsäter, R., Sankaranarayanan, S., Andreasson, U., Fredrikson, S., Gundersen, A., et al. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458508100031 · Cited by 61 · see citing works
Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease
Padhi, D., & Govindaraju, T. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00335 · Cited by 47 · see citing works
Transcriptional and post‐transcriptional regulation of β‐secretase
Tamagno, E., Guglielmotto, M., Monteleone, D., Vercelli, A., & Tabaton, M. (2012) · IUBMB Life · doi:10.1002/iub.1099 · Cited by 40 · see citing works
Fu, Y., Zhen, J., & Lu, Z. (2017) · DNA and Cell Biology · doi:10.1089/dna.2017.3643 · Cited by 38 · see citing works
- Authors
- Sastre, M., Dewachter, I., Rossner, S., Bogdanovic, N., Rosen, E., Borghgraef, P., Evert, B. O., Dumitrescu-Ozimek, L., Thal, D. R., Landreth, G., Walter, J., Klockgether, T., van Leuven, F., & Heneka, M. T.
- Affiliations
- University of Bonn (DE)
- Departments of Neurology and Neuropathology, University of Bonn, Sigmund Freud Strasse 25, 53127 Bonn, Germany; Experimental Genetics Group, Department of Human Genetics, Katholieke Universiteit Leuven, Campus Gasthuisberg O&N 06, B-3000 Leuven, Belgium; Paul Flechsig Institute for Brain Research, Department of Neurochemistry, University of Leipzig, 04109 Leipzig, Germany; Karolinska Institute, Neurotec, Geriatric Department and Huddinge Brain Bank KFC, Novum, Plan4, 14186 Stockholm, Sweden;...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-01-03
- Volume
- 103
- Issue
- 2
- Pages
- 443-448
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1326151
- OpenAlex
- W2147486806
- Cited by
- 373
- References
- 38
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 6 · 2023: 10 · 2022: 13 · 2021: 22 · 2020: 11 · 2019: 13 · 2018: 12 · 2017: 14 · 2016: 16 · 2015: 15 · 2014: 24 · 2013: 22 · 2012: 19
- FWCI
- 23.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
- Document Server@UHasselt (UHasselt) (submittedVersion)
- Funders
- Thomas Jefferson University
- Technische Universität Kaiserslautern
- Deutsche Forschungsgemeinschaft (SFB400)
- KU Leuven
- Université de Lausanne
- Vlaamse regering
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- nonsteroidal anti-inflammatory drugs, PPARγ, BACE1, beta-secretase, Alzheimer's disease, gene promoter activity, transcriptional repression, inflammatory cytokines, amyloid-beta production, neuroinflammation, PPARγ agonists
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Animals, Anti-Inflammatory Agents, Non-Steroidal, Brain, Cells, Cultured, Female, Humans, Ibuprofen, Male, Middle Aged, Endopeptidases, Promoter Regions, Genetic, Transcription, Genetic, Down-Regulation, Cytokines, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Mice, Knockout, PPAR gamma, Mice, Rats, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review